205 reports of this reaction
1.3% of all CALCIUM CHLORIDE reports
#12 most reported adverse reaction
PEMPHIGUS is the #12 most commonly reported adverse reaction for CALCIUM CHLORIDE, manufactured by American Regent, Inc.. There are 205 FDA adverse event reports linking CALCIUM CHLORIDE to PEMPHIGUS. This represents approximately 1.3% of all 15,604 adverse event reports for this drug.
Patients taking CALCIUM CHLORIDE who experience pemphigus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PEMPHIGUS is a less commonly reported adverse event for CALCIUM CHLORIDE, but still significant enough to appear in the safety profile.
In addition to pemphigus, the following adverse reactions have been reported for CALCIUM CHLORIDE:
The following drugs have also been linked to pemphigus in FDA adverse event reports:
PEMPHIGUS has been reported as an adverse event in 205 FDA reports for CALCIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PEMPHIGUS accounts for approximately 1.3% of all adverse event reports for CALCIUM CHLORIDE, making it a notable side effect.
If you experience pemphigus while taking CALCIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.